by Admin | Feb 25, 2022 | News & Opinions
image cation: Paddy Doherty receiving his single infusion of CRISPR-based therapy at a London clinic. (Courtesy of Paddy Doherty) Researchers and patients are excited about recent advancements, but such experiments have their own sets of risks and challenges By Meeri...
by Admin | Feb 25, 2022 | News & Opinions
By Technologynetworks.com – Link to article A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a...
by Admin | Feb 24, 2022 | News & Opinions
By Tasnim Ahmed, CNN – Link to article A US woman has become the third known person who’s gone into HIV remission, and the first mixed-race woman, thanks to a transplant of stem cells from umbilical cord blood, according to research presented at a conference...
by Admin | Feb 24, 2022 | News & Opinions
Written by Carrie Foust – Link to article Researchers at the University of Illinois Chicago found promising results in their search for a treatment to stop nerve cell degeneration that happens in some types of disorders, such as hereditary spastic paraplegia...
by Admin | Feb 23, 2022 | News & Opinions
By Lisa Huiqin Wang – Link to article The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (pictured above) is located at the south end of campus. In November 2021, researchers at the center published a study detailing a new,...
by Admin | Feb 23, 2022 | News & Opinions
Article from Helio.com – Link to article Results from a randomized phase 3 study saw one CAR-T significantly outperform the current standard of care among patients with relapsed or refractory disease, according to study investigator Manali Kamdar, MD. “The...
